Scilex Holding (SCLXW) Shares Outstanding (Diluted Average) (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Shares Outstanding (Diluted Average) of $6.9 million in Q1 2026, up 62352.42% quarter-over-quarter from $11034.0 in Q4 2025, and down 40.42% on a YoY basis from $11.6 million in Q1 2025.

Scilex Holding (SCLXW) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Scilex Holding's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $6.9 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) fell 40.42% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (down 40.42% YoY), while the FY2025 annual figure was $11034.0, up 8.76% from the prior year.
  • Shares Outstanding (Diluted Average) was $6.9 million for Q1 2026 at Scilex Holding, up from $11034.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $134.2 million in Q4 2022 to a low of $2926.0 in Q1 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $40.2 million across 5 years, with a median of $141660.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) tumbled 99.99% in 2024, then jumped 395149.49% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $134.2 million in 2022, then decreased by 2.93% to $130.3 million in 2023, then sank by 99.99% to $10145.0 in 2024, then grew by 8.76% to $11034.0 in 2025, then soared by 62352.42% to $6.9 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $6.9 million (Q1 2026), $11034.0 (Q4 2025), and $11604.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 895.90 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.45 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 544.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.25 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.73 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Scilex Holding - - 4.15 Mn 6.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.89 Mn
Dec 31, 2025 11,034.00
Sep 30, 2025 11,604.00
Jun 30, 2025 11,595.00
Mar 31, 2025 11.57 Mn
Dec 31, 2024 10,145.00
Sep 30, 2024 5,194.00
Jun 30, 2024 3,999.00
Mar 31, 2024 2,926.00
Dec 31, 2023 130.30 Mn
Sep 30, 2023 141,358.00
Jun 30, 2023 142,146.00
Mar 31, 2023 141,660.00
Dec 31, 2022 134.23 Mn
Sep 30, 2022 133.28 Mn
Jun 30, 2022 133.04 Mn
Mar 31, 2022 133.03 Mn
Dec 31, 2021 132.86 Mn
Sep 30, 2021 16.68 Mn
Jun 30, 2021 17.25 Mn